177Lu-JH12

N/A

Report date: 2025/11/24 17:31:44

NME

Base Information

Drug Name177Lu-JH12

Drug Alias Name177Lu-JH12

ClassificationRadiation-emitting products > Radioactive therapeutic agentSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Lutetium > 177Lu +[4]

Mechanisms of ActionC-X-C motif chemokine receptor 4 modulatorsIonising radiation emitters

TargetsC-X-C motif chemokine receptor 4

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesBivision Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesBivision Pharmaceuticals Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A